Quidel Corporation (NASDAQ: QDEL), a primary supplier of speedy diagnostic testing solutions, declared that it has begun taking orders for its QuickVue[R+ lateral motion diagnostic test for infectious mononucleosis. Because of to sturdy buyer motivation, the business has restarted creation its prior mononucleosis products or support with shipments to prospects anticipated about the to start with week of August (see also Mononucleosis). "Our stop consumers have expressed a impressive inspiration for us to offer again our IgM-specific QuickVue+ Infectious Mononucleosis examination. This examination will strengthen our present QuickVue respiratory franchise, when leveraging our QuickVue manufacturing efficiencies." My websites: mononucleosis infor